These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 12828063

  • 1. Preoperative serum level of CA19-9 predicts recurrence after curative surgery in node-negative colorectal cancer patients.
    Nakagoe T, Sawai T, Tsuji T, Jibiki MA, Nanashima A, Yamaguchi H, Yasutake T, Ayabe H, Arisawa K.
    Hepatogastroenterology; 2003; 50(51):696-9. PubMed ID: 12828063
    [Abstract] [Full Text] [Related]

  • 2. Serological studies on CEA, CA 19-9, STn and SLX in colorectal cancer.
    Sato T, Nishimura G, Nonomura A, Miwa K, Miyazaki I.
    Hepatogastroenterology; 1999; 46(26):914-9. PubMed ID: 10370638
    [Abstract] [Full Text] [Related]

  • 3. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R, Fujii S, Ohta M, Nagano Y, Kunisaki C, Yamagishi S, Osada S, Ichikawa Y, Shimada H.
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [Abstract] [Full Text] [Related]

  • 4. Preoperative serum levels of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens as prognostic markers after curative resection for colorectal cancer.
    Nakagoe T, Sawai T, Tsuji T, Jibiki MA, Nanashima A, Yamaguchi H, Yasutake T, Kurosaki N, Ayabe H, Arisawa K.
    Cancer Detect Prev; 2001 Dec; 25(3):299-308. PubMed ID: 11425272
    [Abstract] [Full Text] [Related]

  • 5. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?
    Chen CC, Yang SH, Lin JK, Lin TC, Chen WS, Jiang JK, Wang HS, Chang SC.
    J Surg Res; 2005 Apr; 124(2):169-74. PubMed ID: 15820244
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens expression levels as predictors of recurrence after curative surgery in node-negative colorectal cancer patients.
    Nakagoe T, Fukushima K, Tanaka K, Sawai T, Tsuji T, Jibiki M, Nanashima A, Yamaguchi H, Yasutake T, Ayabe H, Arisawa K.
    J Exp Clin Cancer Res; 2002 Mar; 21(1):107-13. PubMed ID: 12071515
    [Abstract] [Full Text] [Related]

  • 7. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
    Lai IR, Lee WJ, Huang MT, Lin HH.
    Hepatogastroenterology; 2002 Mar; 49(46):1157-60. PubMed ID: 12143226
    [Abstract] [Full Text] [Related]

  • 8. Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level.
    Park IJ, Choi GS, Lim KH, Kang BM, Jun SH.
    Ann Surg Oncol; 2009 Nov; 16(11):3087-93. PubMed ID: 19629600
    [Abstract] [Full Text] [Related]

  • 9. Serum carcinoembryonic antigen levels in patients operated for colorectal carcinoma.
    Veingerl B.
    Wien Klin Wochenschr; 2001 Nov; 113 Suppl 3():32-8. PubMed ID: 15503618
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of serum tumor antigen CA19-9 after curative resection of colorectal cancer.
    Park IJ, Choi GS, Jun SH.
    Anticancer Res; 2009 Oct; 29(10):4303-8. PubMed ID: 19846991
    [Abstract] [Full Text] [Related]

  • 11. Predictive factors for preoperative serum levels of sialy Lewis(x), sialyl Lewis(a) and sialyl Tn antigens in gastric cancer patients.
    Nakagoe T, Sawai T, Tsuji T, Jibiki MA, Nanashima A, Yamaguchi H, Yasutake T, Ayabe H, Arisawa K, Ishikawa H.
    Anticancer Res; 2002 Oct; 22(1A):451-8. PubMed ID: 12017332
    [Abstract] [Full Text] [Related]

  • 12. CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer.
    Wang WS, Lin JK, Chiou TJ, Liu JH, Fan FS, Yen CC, Lin TC, Jiang JK, Yang SH, Wang HS, Chen PM.
    Hepatogastroenterology; 2002 Oct; 49(43):160-4. PubMed ID: 11941943
    [Abstract] [Full Text] [Related]

  • 13. Undetectable preoperative levels of serum CA 19-9 correlate with improved survival for patients with resectable pancreatic adenocarcinoma.
    Berger AC, Meszoely IM, Ross EA, Watson JC, Hoffman JP.
    Ann Surg Oncol; 2004 Jul; 11(7):644-9. PubMed ID: 15197014
    [Abstract] [Full Text] [Related]

  • 14. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.
    Gasser M, Gerstlauer C, Grimm M, Bueter M, Lebedeva T, Lutz J, Maeder U, Ribas C, Ribas C, Nichiporuk E, Thalheimer A, Heemann U, Thiede A, Meyer D, Waaga-Gasser AM.
    Ann Surg Oncol; 2007 Apr; 14(4):1272-84. PubMed ID: 17211733
    [Abstract] [Full Text] [Related]

  • 15. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
    Tang R, Yeh CY, Wang JY, Changchien CR, Chen JS, Hsieh LL.
    Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285
    [Abstract] [Full Text] [Related]

  • 16. Metastatic potential in T1 and T2 colorectal cancer.
    Fang WL, Chang SC, Lin JK, Wang HS, Yang SH, Jiang JK, Chen WC, Lin TC.
    Hepatogastroenterology; 2005 Sep; 52(66):1688-91. PubMed ID: 16334758
    [Abstract] [Full Text] [Related]

  • 17. Value of serum carbohydrate antigen 19-9 for predicting extrahepatic metastasis in patients with liver metastasis from colorectal carcinoma.
    Sasaki A, Kawano K, Inomata M, Shibata K, Matsumoto T, Kitano S.
    Hepatogastroenterology; 2005 Sep; 52(66):1814-9. PubMed ID: 16334783
    [Abstract] [Full Text] [Related]

  • 18. Increased serum level of sialyl Lewis(x) antigen in blood from the tumor drainage vein in patients with non-polypoid growth type of colorectal cancer.
    Nakagoe T, Sawai T, Tsuji T, Jibiki M, Ohbatake M, Nanashima A, Yamaguchi H, Kurosaki N, Yasutake T, Ayabe H, Arisawa K.
    J Exp Clin Cancer Res; 2001 Mar; 20(1):85-90. PubMed ID: 11370835
    [Abstract] [Full Text] [Related]

  • 19. The use of tumor markers as predictors of prognosis in gastric cancer.
    Mihmanli M, Dilege E, Demir U, Coskun H, Eroglu T, Uysalol MD.
    Hepatogastroenterology; 2004 Mar; 51(59):1544-7. PubMed ID: 15362797
    [Abstract] [Full Text] [Related]

  • 20. Pre-operative serum levels of sialyl Tn antigen predict liver metastasis and poor prognosis in patients with gastric cancer.
    Nakagoe T, Sawai T, Tsuji T, Jibiki M, Nanashima A, Yamaguchi H, Yasutake T, Ayabe H, Arisawa K, Ishikawa H.
    Eur J Surg Oncol; 2001 Dec; 27(8):731-9. PubMed ID: 11735169
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.